Cargando…

Multimorbidity, psychoactive substance use and psychological distress among acute medically ill patients: a cross-sectional study

BACKGROUND: In order to target the complex health needs of patients with multimorbidity using psychoactive substances, knowledge regarding the association between substance use and multimorbidity in an acute setting is needed. AIMS: Examine psychoactive substance use patterns among acute medically i...

Descripción completa

Detalles Bibliográficos
Autores principales: Kabashi, Saranda, Gamboa, Danil, Vindenes, Vigdis, Berg, Thomas, Hilberg, Thor Arthur, Jørgenrud, Benedicte, Lerdal, Anners, Bogstrand, Stig Tore
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8611427/
https://www.ncbi.nlm.nih.gov/pubmed/34815283
http://dx.doi.org/10.1136/bmjopen-2021-052428
_version_ 1784603293544087552
author Kabashi, Saranda
Gamboa, Danil
Vindenes, Vigdis
Berg, Thomas
Hilberg, Thor Arthur
Jørgenrud, Benedicte
Lerdal, Anners
Bogstrand, Stig Tore
author_facet Kabashi, Saranda
Gamboa, Danil
Vindenes, Vigdis
Berg, Thomas
Hilberg, Thor Arthur
Jørgenrud, Benedicte
Lerdal, Anners
Bogstrand, Stig Tore
author_sort Kabashi, Saranda
collection PubMed
description BACKGROUND: In order to target the complex health needs of patients with multimorbidity using psychoactive substances, knowledge regarding the association between substance use and multimorbidity in an acute setting is needed. AIMS: Examine psychoactive substance use patterns among acute medically ill patients, and determine the association between multimorbidity and substance use, and psychological distress. DESIGN: Cross-sectional study. SETTING AND PARTICIPANTS: 2874 acute medically ill patients admitted to a medical emergency department in Oslo, Norway. MEASUREMENTS: Primary outcome: multimorbidity recorded by the presence of ≥2 International Classification of Diseases 10th revision—physical and/or mental health conditions per patient, extracted from medical records. Predictor variables: self-reported data on age, sex, occupational status, psychological distress (Hopkins Symptom Check List-5), alcohol use (Alcohol Use Disorder Identification Test-4) and results from blood samples on psychoactive medicinal and illicit drugs. FINDINGS: Of all patients, 57.2% had multimorbidity. Of these, 62.6% reported psychological distress, 85.5% consumed either alcohol, medicinal and/or illicit drugs and 64.4% combined alcohol with psychoactive medicinal drugs. Patients with risky alcohol use were more likely to have multimorbidity compared with patients with low-risk alcohol use (OR 1.53; 95% CI 1.05 to 2.24). Patients using psychoactive medicinal drugs were more likely to have multimorbidity compared with non-users (OR 1.34; 95% CI 1.07 to 1.67). CONCLUSION: Multimorbidity was associated with psychoactive medicinal drug and risky alcohol use, and psychological distress. Substance use was widespread, with alcohol and psychoactive medicinal drugs most frequently combined. Monitoring substance use among multimorbid patients is necessary to develop tailored treatments, and reduce burden on the healthcare system.
format Online
Article
Text
id pubmed-8611427
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-86114272021-12-10 Multimorbidity, psychoactive substance use and psychological distress among acute medically ill patients: a cross-sectional study Kabashi, Saranda Gamboa, Danil Vindenes, Vigdis Berg, Thomas Hilberg, Thor Arthur Jørgenrud, Benedicte Lerdal, Anners Bogstrand, Stig Tore BMJ Open Addiction BACKGROUND: In order to target the complex health needs of patients with multimorbidity using psychoactive substances, knowledge regarding the association between substance use and multimorbidity in an acute setting is needed. AIMS: Examine psychoactive substance use patterns among acute medically ill patients, and determine the association between multimorbidity and substance use, and psychological distress. DESIGN: Cross-sectional study. SETTING AND PARTICIPANTS: 2874 acute medically ill patients admitted to a medical emergency department in Oslo, Norway. MEASUREMENTS: Primary outcome: multimorbidity recorded by the presence of ≥2 International Classification of Diseases 10th revision—physical and/or mental health conditions per patient, extracted from medical records. Predictor variables: self-reported data on age, sex, occupational status, psychological distress (Hopkins Symptom Check List-5), alcohol use (Alcohol Use Disorder Identification Test-4) and results from blood samples on psychoactive medicinal and illicit drugs. FINDINGS: Of all patients, 57.2% had multimorbidity. Of these, 62.6% reported psychological distress, 85.5% consumed either alcohol, medicinal and/or illicit drugs and 64.4% combined alcohol with psychoactive medicinal drugs. Patients with risky alcohol use were more likely to have multimorbidity compared with patients with low-risk alcohol use (OR 1.53; 95% CI 1.05 to 2.24). Patients using psychoactive medicinal drugs were more likely to have multimorbidity compared with non-users (OR 1.34; 95% CI 1.07 to 1.67). CONCLUSION: Multimorbidity was associated with psychoactive medicinal drug and risky alcohol use, and psychological distress. Substance use was widespread, with alcohol and psychoactive medicinal drugs most frequently combined. Monitoring substance use among multimorbid patients is necessary to develop tailored treatments, and reduce burden on the healthcare system. BMJ Publishing Group 2021-11-23 /pmc/articles/PMC8611427/ /pubmed/34815283 http://dx.doi.org/10.1136/bmjopen-2021-052428 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Addiction
Kabashi, Saranda
Gamboa, Danil
Vindenes, Vigdis
Berg, Thomas
Hilberg, Thor Arthur
Jørgenrud, Benedicte
Lerdal, Anners
Bogstrand, Stig Tore
Multimorbidity, psychoactive substance use and psychological distress among acute medically ill patients: a cross-sectional study
title Multimorbidity, psychoactive substance use and psychological distress among acute medically ill patients: a cross-sectional study
title_full Multimorbidity, psychoactive substance use and psychological distress among acute medically ill patients: a cross-sectional study
title_fullStr Multimorbidity, psychoactive substance use and psychological distress among acute medically ill patients: a cross-sectional study
title_full_unstemmed Multimorbidity, psychoactive substance use and psychological distress among acute medically ill patients: a cross-sectional study
title_short Multimorbidity, psychoactive substance use and psychological distress among acute medically ill patients: a cross-sectional study
title_sort multimorbidity, psychoactive substance use and psychological distress among acute medically ill patients: a cross-sectional study
topic Addiction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8611427/
https://www.ncbi.nlm.nih.gov/pubmed/34815283
http://dx.doi.org/10.1136/bmjopen-2021-052428
work_keys_str_mv AT kabashisaranda multimorbiditypsychoactivesubstanceuseandpsychologicaldistressamongacutemedicallyillpatientsacrosssectionalstudy
AT gamboadanil multimorbiditypsychoactivesubstanceuseandpsychologicaldistressamongacutemedicallyillpatientsacrosssectionalstudy
AT vindenesvigdis multimorbiditypsychoactivesubstanceuseandpsychologicaldistressamongacutemedicallyillpatientsacrosssectionalstudy
AT bergthomas multimorbiditypsychoactivesubstanceuseandpsychologicaldistressamongacutemedicallyillpatientsacrosssectionalstudy
AT hilbergthorarthur multimorbiditypsychoactivesubstanceuseandpsychologicaldistressamongacutemedicallyillpatientsacrosssectionalstudy
AT jørgenrudbenedicte multimorbiditypsychoactivesubstanceuseandpsychologicaldistressamongacutemedicallyillpatientsacrosssectionalstudy
AT lerdalanners multimorbiditypsychoactivesubstanceuseandpsychologicaldistressamongacutemedicallyillpatientsacrosssectionalstudy
AT bogstrandstigtore multimorbiditypsychoactivesubstanceuseandpsychologicaldistressamongacutemedicallyillpatientsacrosssectionalstudy